IL157590A0 - Carbamate compounds for use in preventing or treating bipolar disorder - Google Patents

Carbamate compounds for use in preventing or treating bipolar disorder

Info

Publication number
IL157590A0
IL157590A0 IL15759002A IL15759002A IL157590A0 IL 157590 A0 IL157590 A0 IL 157590A0 IL 15759002 A IL15759002 A IL 15759002A IL 15759002 A IL15759002 A IL 15759002A IL 157590 A0 IL157590 A0 IL 157590A0
Authority
IL
Israel
Prior art keywords
preventing
bipolar disorder
phenyl
alkyl
treating bipolar
Prior art date
Application number
IL15759002A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL157590A0 publication Critical patent/IL157590A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
IL15759002A 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder IL157590A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
PCT/US2002/005297 WO2002067921A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number Publication Date
IL157590A0 true IL157590A0 (en) 2004-03-28

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15759002A IL157590A0 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Country Status (27)

Country Link
US (1) US6562867B2 (xx)
EP (1) EP1408953B1 (xx)
JP (1) JP4276837B2 (xx)
KR (1) KR100946944B1 (xx)
CN (1) CN1250215C (xx)
AT (1) ATE324108T1 (xx)
BR (1) BR0207644A (xx)
CA (1) CA2439475C (xx)
CY (1) CY1105330T1 (xx)
CZ (1) CZ20032300A3 (xx)
DE (1) DE60210976T2 (xx)
DK (1) DK1408953T3 (xx)
ES (1) ES2262801T3 (xx)
HK (1) HK1063436A1 (xx)
HU (1) HUP0303243A3 (xx)
IL (1) IL157590A0 (xx)
MX (1) MXPA03007717A (xx)
MY (1) MY129304A (xx)
NO (1) NO20033802L (xx)
NZ (1) NZ527988A (xx)
PL (1) PL364638A1 (xx)
PT (1) PT1408953E (xx)
RS (1) RS50677B (xx)
RU (1) RU2300372C2 (xx)
TW (1) TWI250872B (xx)
WO (1) WO2002067921A1 (xx)
ZA (1) ZA200307465B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL365701A1 (en) * 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
RU2300373C2 (ru) * 2001-02-27 2007-06-10 Орто-Макнейл Фармасьютикал, Инк. Карбаматы для предотвращения или лечения нейродегенеративных нарушений
NZ546549A (en) 2001-02-27 2007-11-30 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating anxiety disorders
BR0211244A (pt) 2001-07-16 2004-07-27 Ortho Mcneil Pharm Inc Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada com cefaléia em salvas e enxaqueca
BRPI0515374A (pt) * 2004-09-16 2008-07-22 Janssen Pharmaceutica Nv métodos de tratamento de epileptogenêse e epilepsia
CA2611713C (en) 2005-06-08 2013-10-01 Sk Holdings Co., Ltd. Treatment of sleep-wake disorders
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
BRPI0718323A2 (pt) * 2006-10-31 2013-11-26 Janssen Pharmaceutica Nv Tratamento de transtornos invasivos do desenvolvimento.
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN105189451A (zh) * 2013-03-12 2015-12-23 比皮艾思药物研发有限公司 氨基甲酸苯酯化合物和包含该化合物的用于预防或治疗神经性毒气引起的疾病的组合物
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
JP7208139B2 (ja) 2016-12-14 2023-01-18 エスケー バイオファーマスティカルズ カンパニー リミテッド 双極性障害の予防、軽減又は治療のためのカルバメート化合物の使用
EP3630072A4 (en) 2017-06-02 2021-03-10 Jazz Pharmaceuticals Ireland Limited METHODS AND COMPOSITIONS FOR TREATMENT OF EXCESSIVE Drowsiness
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
MXPA03007717A (es) 2005-11-08
NZ527988A (en) 2006-01-27
CY1105330T1 (el) 2010-03-03
ATE324108T1 (de) 2006-05-15
CZ20032300A3 (cs) 2005-01-12
CA2439475C (en) 2010-05-18
ZA200307465B (en) 2005-03-17
RU2300372C2 (ru) 2007-06-10
KR20030087010A (ko) 2003-11-12
RU2003128997A (ru) 2005-03-20
RS50677B (sr) 2010-06-30
EP1408953A1 (en) 2004-04-21
EP1408953B1 (en) 2006-04-26
US6562867B2 (en) 2003-05-13
PL364638A1 (en) 2004-12-13
ES2262801T3 (es) 2006-12-01
US20020198257A1 (en) 2002-12-26
MY129304A (en) 2007-03-30
PT1408953E (pt) 2006-07-31
DE60210976T2 (de) 2007-05-24
JP2004533415A (ja) 2004-11-04
HUP0303243A2 (hu) 2004-01-28
NO20033802L (no) 2003-10-22
NO20033802D0 (no) 2003-08-26
DK1408953T3 (da) 2006-08-21
DE60210976D1 (de) 2006-06-01
JP4276837B2 (ja) 2009-06-10
YU67803A (sh) 2006-08-17
KR100946944B1 (ko) 2010-03-15
CN1250215C (zh) 2006-04-12
TWI250872B (en) 2006-03-11
BR0207644A (pt) 2004-03-09
HK1063436A1 (en) 2004-12-31
WO2002067921A1 (en) 2002-09-06
CA2439475A1 (en) 2002-09-06
CN1505506A (zh) 2004-06-16
HUP0303243A3 (en) 2012-07-30

Similar Documents

Publication Publication Date Title
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
IL157590A0 (en) Carbamate compounds for use in preventing or treating bipolar disorder
YU68003A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
RS67603A (xx) Karbamatna jedinjenja za upotrebu u lečenju bola
IL157594A0 (en) Carbamate compounds for use in preventing or treating anxiety disorders
RS67503A (xx) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju psihotičnih poremećaja
AU7349301A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
IL159847A0 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
HK1063288A1 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees